GGrantIndex
← Leaderboards

David M Nathan

Massachusetts Institute Of Technology

$156,869,844
Attributed
$276,846,042
Total exposure
29
Grants
18
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $33.9M · FY200525
$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$343,117,609 · 30

By mechanism

U01$273,945,460 · 3
U19$66,271,567 · 1
M01$2,272,488 · 25
U34$628,094 · 1

Top collaborators

Others in their field

Top investigators on “Diabetes Mellitus

Research focus

Diabetes MellitusMetforminNon-Insulin-Dependent Diabetes MellitusCardiovascular DiseasesIncidencePersonsCardiovascular Disorder RiskClinical TrialsFollow-UpParticipantRandomizedRisk FactorsMetabolicPharmaceutical PreparationsAffectCohortLifestyle InterventionPreventQuality Of LifeHuman SubjectFundingWeight GainObesityClinical Research

Grant awards (117)

Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$15,462,979
U19 · FY2025 · AG
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,500,642
U19 · FY2024 · AG
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$250,000
U19 · FY2024 · AG
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,850,168
U19 · FY2023 · AG
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$250,000
U19 · FY2023 · AG
Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project$16,957,778
U19 · FY2022 · AG
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study$3,162,825
U01 · FY2022 · DK
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study$7,183,299
U01 · FY2021 · DK
11/22 Limited Competition for the Continuation of the Diabetes Prevention Program Outcomes Study (DPPOS) - Clinical Center$465,565
U01 · FY2021 · DK · contact PI
04/16 Action for Health in Diabetes Extension Study Research Project$413,929
U01 · FY2020 · DK · contact PI
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$396,614
U01 · FY2020 · DK · contact PI
04/16 Action for Health in Diabetes Extension Study Research Project$69,299
U01 · FY2020 · DK · contact PI
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study$26,924,216
U01 · FY2019 · DK
04/16 Action for Health in Diabetes Extension Study Research Project$505,384
U01 · FY2019 · DK · contact PI
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$427,720
U01 · FY2019 · DK · contact PI
04/16 Action for Health in Diabetes Extension Study Research Project$65,498
U01 · FY2019 · DK · contact PI
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study$30,855,577
U01 · FY2018 · DK
04/16 Action for Health in Diabetes Extension Study Research Project$508,616
U01 · FY2018 · DK · contact PI
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study$498,960
U01 · FY2018 · DK
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$432,262
U01 · FY2018 · DK · contact PI
04/16 Action for Health in Diabetes Extension Study Research Project$107,604
U01 · FY2018 · DK · contact PI
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study$30,477,617
U01 · FY2017 · DK
Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study$2,499,231
U01 · FY2017 · DK
04/16 Action for Health in Diabetes Extension Study Research Project$518,759
U01 · FY2017 · DK · contact PI
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$430,979
U01 · FY2017 · DK · contact PI
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study$29,980,562
U01 · FY2016 · DK
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study$1,460,731
U01 · FY2016 · DK
04/16 Action for Health in Diabetes Extension Study Research Project$548,882
U01 · FY2016 · DK · contact PI
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$375,249
U01 · FY2016 · DK · contact PI
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$36,830
U01 · FY2016 · DK · contact PI
11/22 Diabetes Prevention Program Outcomes Study (DPPOS) Phase 3 - Research Project$25,817
U01 · FY2016 · DK · contact PI
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study$28,947,476
U01 · FY2015 · DK
DPPOS Follow-up$450,548
U01 · FY2015 · DK · contact PI
Action for Health in Diabetes Continuation(Look AHEAD-C)$69,405
U01 · FY2015 · DK · contact PI
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study$27,693,077
U01 · FY2014 · DK
Action for Health in Diabetes Continuation(Look AHEAD-C)$924,088
U01 · FY2014 · DK · contact PI
Diabetes Prevention Program Outcome Study - Phase 2$638,029
U01 · FY2014 · DK · contact PI
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study$25,963,369
U01 · FY2013 · DK
Action for Health in Diabetes Continuation(Look AHEAD-C)$1,055,363
U01 · FY2013 · DK · contact PI
Diabetes Prevention Program Outcome Study - Phase 2$663,938
U01 · FY2013 · DK · contact PI
Glycemia Reduction Approaches in Diabetes: A comparative effectiveness study$23,251,182
U01 · FY2012 · DK
Action for Health in Diabetes (Look AHEAD)$1,595,718
U01 · FY2012 · DK · contact PI
Diabetes Prevention Program Outcome Study - Phase 2$687,564
U01 · FY2012 · DK · contact PI
Action for Health in Diabetes (Look AHEAD)$1,597,345
U01 · FY2011 · DK · contact PI
Diabetes Prevention Program Outcome Study - Phase 2$652,486
U01 · FY2011 · DK · contact PI
Glycemic Reduction Approaches for Treating Diabetes: An Effectiveness Study$309,026
U34 · FY2011 · DK · contact PI
Action for Health in Diabetes (Look AHEAD)$1,546,953
U01 · FY2010 · DK · contact PI
Diabetes Prevention Program Outcome Study - Phase 2$581,594
U01 · FY2010 · DK · contact PI
Glycemic Reduction Approaches for Treating Diabetes: An Effectiveness Study$319,068
U34 · FY2010 · DK · contact PI
Action for Health in Diabetes (Look AHEAD)$1,514,130
U01 · FY2009 · DK · contact PI
Diabetes Prevention Program Outcome Study - Phase 2$543,233
U01 · FY2009 · DK · contact PI
Action for Health in Diabetes (Look AHEAD)$135,258
U01 · FY2009 · DK · contact PI
Action for Health in Diabetes (Look AHEAD)$1,416,848
U01 · FY2008 · DK · contact PI
Post-DPP Followup Study$490,671
U01 · FY2008 · DK · contact PI
COMPARISON OF LANTUS AND NPH INSULIN IN THE DAWN PHENOMENON$5,828
M01 · FY2008 · RR · contact PI
LOOK AHEAD: ACTION FOR HEALTH IN DIABETES$5,018
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: TODAY$2,752
M01 · FY2008 · RR · contact PI
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY)$1,457
M01 · FY2008 · RR · contact PI
CLINICAL TRIAL: DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)$971
M01 · FY2008 · RR · contact PI
Action for Health in Diabetes (Look AHEAD)$1,448,126
U01 · FY2007 · DK · contact PI
Post-DPP Followup Study$497,351
U01 · FY2007 · DK · contact PI
LOOK AHEAD: ACTION FOR HEALTH IN DIABETES$24,432
M01 · FY2007 · RR · contact PI
TODAY$6,430
M01 · FY2007 · RR · contact PI
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY)$5,787
M01 · FY2007 · RR · contact PI
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)$2,572
M01 · FY2007 · RR · contact PI
ASSESSING ENERGY NEEDS OF OVERWEIGHT AND OBESE INDIVIDUALS: A COMPARISON OF ME$1,286
M01 · FY2007 · RR · contact PI
Action for Health in Diabetes (Look AHEAD)$863,970
U01 · FY2006 · DK · contact PI
Post-DPP Followup Study$392,975
U01 · FY2006 · DK · contact PI
ASSESSING ENERGY NEEDS OF OVERWEIGHT AND OBESE INDIVIDUALS: A COMPARISON OF ME$25,874
M01 · FY2006 · RR · contact PI
LOOK AHEAD: ACTION FOR HEALTH IN DIABETES$10,267
M01 · FY2006 · RR · contact PI
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)$3,286
M01 · FY2006 · RR · contact PI
TODAY$2,464
M01 · FY2006 · RR · contact PI
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY)$1,642
M01 · FY2006 · RR · contact PI
SHOW PROJECT$1,572,309
U01 · FY2005 · DK
Post-DPP Followup Study$491,226
U01 · FY2005 · DK
PARTNERS ROCHE TYPE 2 DIABETES PROJECT$132,444
M01 · FY2005 · RR
LOOK AHEAD: ACTION FOR HEALTH IN DIABETES$21,516
M01 · FY2005 · RR
ASSESSING ENERGY NEEDS OF OVERWEIGHT AND OBESE INDIVIDUALS: A COMPARISON OF ME$10,998
M01 · FY2005 · RR
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)$3,347
M01 · FY2005 · RR
TREATMENT OPTIONS FOR TYPE 2 DIABETES IN ADOLESCENTS AND YOUTH (TODAY)$1,434
M01 · FY2005 · RR
TODAY$478
M01 · FY2005 · RR
SHOW PROJECT$1,100,141
U01 · FY2004 · DK
Post-DPP Followup Study$446,758
U01 · FY2004 · DK
PARTNERS ROCHE TYPE 2 DIABETES PROJECT$129,418
M01 · FY2004 · RR
LOOK AHEAD: ACTION FOR HEALTH IN DIABETES$60,838
M01 · FY2004 · RR
DIABETES PREVENTION PROGRAM OUTCOMES STUDY (DPPOS)$2,212
M01 · FY2004 · RR
DIABETES PREVENTION PROGRAM (DPP)$1,100
M01 · FY2004 · RR
SHOW PROJECT$1,716,267
U01 · FY2003 · DK
Post-DPP Followup Study$578,826
U01 · FY2003 · DK
SHOW PROJECT$6,100
U01 · FY2003 · DK
Clinical Center for Look AHEAD: Health in Diabetes$1,544,625
U01 · FY2002 · DK
DIABETES PREVENTION PROGRAM (DDP-2)$521,119
U01 · FY2002 · DK
DIABETES PREVENTION PROGRAM$200,768
M01 · FY2002 · RR
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE$200,768
M01 · FY2002 · RR
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE$200,768
M01 · FY2002 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS (EDIC)$200,768
M01 · FY2002 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS (EDIC)$200,768
M01 · FY2002 · RR
DIABETES PREVENTION PROGRAM$200,768
M01 · FY2002 · RR
Clinical Center for Look AHEAD: Health in Diabetes$6,100
U01 · FY2002 · DK
Clinical Center for Look AHEAD: Health in Diabetes$1,249,457
U01 · FY2001 · DK
DIABETES PREVENTION PROGRAM (DDP-2)$956,277
U01 · FY2001 · DK
DIABETES PREVENTION PROGRAM$200,768
M01 · FY2001 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS (EDIC)$200,768
M01 · FY2001 · RR
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE$200,768
M01 · FY2001 · RR
Clinical Center for Look AHEAD: Health in Diabetes$6,100
U01 · FY2001 · DK
DIABETES PREVENTION PROGRAM$0
M01 · FY2001 · RR
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE$0
M01 · FY2001 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS (EDIC)$0
M01 · FY2001 · RR
Clinical Center for Look AHEAD: Health in Diabetes$947,398
U01 · FY2000 · DK
DIABETES PREVENTION PROGRAM (DDP-2)$810,035
U01 · FY2000 · DK
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS (EDIC)$575
M01 · FY2000 · RR
DIABETES PREVENTION PROGRAM$575
M01 · FY2000 · RR
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE$575
M01 · FY2000 · RR
DIABETES PREVENTION PROGRAM$0
M01 · FY2000 · RR
ADMINISTRATION OF GLP 1 BY SUBCUTANEOUS DELIVERY--DETERMINATION OF DOSE$0
M01 · FY2000 · RR
EPIDEMIOLOGY OF DIABETES INTERVENTION &COMPLICATIONS (EDIC)$0
M01 · FY2000 · RR
Diabetes prevention program: Screening step 2$0
M01 · FY2000 · RR